EpiBiome

EpiBiome, Inc., based in South San Francisco, CA, is a microbiome precision engineering biotechnology company that employs a genomics approach to develop therapies to control and treat microbial infections. EpiBiome’s technology platform consists of “bacteriophages,” or viruses that infect only bacteria, which are selected from the environment to specifically target the pathogens. By imitating nature’s form of bacterial control, this technology addresses growing public health concerns over the use of antibiotics.